KIRSTIN FURMAN: Open Payments
NPI 1194308841 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 61 payments from 21 companies in 2025. Trend: 2023 $1,642 · 2024 $613 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $325 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $211 |
| Astellas Pharma US Inc | 2 | $153 |
| GlaxoSmithKline, LLC. | 1 | $124 |
| PFIZER INC. | 4 | $74 |
| Novo Nordisk Inc | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Lilly USA, LLC | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
Products named: NEFFY, QULIPTA, Veozah, AREXVY, UBRELVY, AIRSUPRA, NURTEC ODT, GARDASIL 9.
Industry payments across AR — which companies pay providers there.
